fbpx

Study for People with Type 2 Diabetes who Take Metformin

About 38 million Americans (1 in 10) have diabetes, and about 90-95% of those have Type II Diabetes according to the CDC.  It is estimated that more than two-thirds of US adults are overweight or have obesity.  Both are significant health issues which affect millions. Are you among those who struggle with weight and glucose control?  This research study might be of benefit to you.

The FDA approved the study drug in May 2022 under the indication of improving glucose control in conjunction with diet and exercise for adults with Type II Diabetes. In November 2023, the study drug was approved by the FDA for chronic weight management for overweight adults and adults with obesity, who also have one weight-related condition, in combination with a reduced calorie diet and increase physical activity.

Currently there are no data for dosing of the study drug at higher doses than 15 mg in comparison to a placebo.

The purpose of this trial is to evaluate the safety and effectiveness of the study drug at higher doses as compared to a placebo (6:1).  Participants will have frequent exercise and dietary counseling at their appointments.

  1. Commitment to lose weight and better glucose control
  2. Weekly injections with study drug
  3. Blood glucose monitoring at home with supplies provided
  4. Dosing from 44 to 80 weeks with up to 18 appointments
  1. Must be 18 to 75 years of age
  2. HBA1c of >7% and < 10%
  3. Be on a stable dose of Metformin
  4. Willing to self-dose injectable research medication once a week

You may call our office at 615-329-2222 and speak with our team or fill out the form above.  Our team will need to speak with you to gauge your interest and make sure that you qualify for participation.

All study related diagnostic tests and study medication are at no cost.  Insurance is not required. 

Compensation of up to $3,000 may be included.

Please fill out the information below.

Our team will be in touch with you as soon as possible to discuss the study with you.

Name(Required)
Is it OK if we text you?*(Required)
Your subscriber information is collected for the sole purpose of sending you messages related to the program content. Your subscriber information will not be sold, rented, or otherwise shared except where applicable by law. SMS Terms and Conditions: By entering your mobile number, you agree to receive promotional or informational text messages to the number you provide. Msg and data rates may apply; Msg frequency varies. Reply STOP to cancel. Contact support at (615) 329-2222 or info@clinicalresearchassociates.com
MM slash DD slash YYYY
Do You Live with Any of the Following Conditions?
Please select which medicine(s) you take for diabetes
Read About Why We Need To Know Beneath This Form
Have you ever in your life experienced any of the following? Please select all that apply.
How would you describe yourself?*
*Please check all that apply.
This field is for validation purposes and should be left unchanged.